Chira, E. C., McMillen, T. S., Wang, S., Haw, A., O’Brien, K. D., Wight, T. N., & Chait, A. (2007). Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, reduces atherosclerosis in female low density lipoprotein receptor deficient mice.

Chira, Ebele C., Timothy S. McMillen, Shari Wang, Antonio Haw, Kevin D. O’Brien, Thomas N. Wight, and Alan Chait. Tesaglitazar, a Dual Peroxisome Proliferator-activated Receptor Alpha/gamma Agonist, Reduces Atherosclerosis in Female Low Density Lipoprotein Receptor Deficient Mice. 2007.

Chira, Ebele C., et al. Tesaglitazar, a Dual Peroxisome Proliferator-activated Receptor Alpha/gamma Agonist, Reduces Atherosclerosis in Female Low Density Lipoprotein Receptor Deficient Mice. 2007.